Unilife Signs Agreement with Global Pharmaceutical Company Seeking to Use Ocu-Ject

Unilife (NASDAQ: UNIS ) today announced the signing of an agreement with a global pharmaceutical company seeking to use the Unilife Ocu-ject™ ocular drug delivery system to deliver a target injectable therapy into the eye. The identity of the global pharmaceutical company, one of the market leaders in ophthalmic therapies,